Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 479

1.

[Correlation of PBX2/ELF2 expression with prognosis of non-small cell lung cancer].

Jin SQ, Pu YF, Qiu Y, Aozasa K, Morii E.

Zhejiang Da Xue Xue Bao Yi Xue Ban. 2014 Jul;43(4):413-9. Chinese.

PMID:
25187455
2.

A point mutation in Semaphorin 4A associates with defective endosomal sorting and causes retinal degeneration.

Nojima S, Toyofuku T, Kamao H, Ishigami C, Kaneko J, Okuno T, Takamatsu H, Ito D, Kang S, Kimura T, Yoshida Y, Morimoto K, Maeda Y, Ogata A, Ikawa M, Morii E, Aozasa K, Takagi J, Takahashi M, Kumanogoh A.

Nat Commun. 2013;4:1406. doi: 10.1038/ncomms2420.

3.

Current status of the Japanese society of pathology with its 100th anniversary.

Aozasa K.

Japan Med Assoc J. 2012 Sep;55(5):416-8. No abstract available.

PMID:
25237262
4.

Inhibitory effect of PPARĪ³ on NR0B1 in tumorigenesis of lung adenocarcinoma.

Susaki Y, Inoue M, Minami M, Sawabata N, Shintani Y, Nakagiri T, Funaki S, Aozasa K, Okumura M, Morii E.

Int J Oncol. 2012 Oct;41(4):1278-84. doi: 10.3892/ijo.2012.1571. Epub 2012 Jul 25.

PMID:
22843091
5.

Prognostic significance of elongator protein 3 expression in endometrioid adenocarcinoma.

Wang Y, Ikeda JI, Rahadiani N, Mamat S, Ueda Y, Tian T, Enomoto T, Kimura T, Aozasa K, Morii E.

Oncol Lett. 2012 Jan;3(1):25-29. Epub 2011 Sep 22.

6.

Transcriptional Regulation of Aldehyde Dehydrogenase 1A1 Gene by Alternative Spliced Forms of Nuclear Factor Y in Tumorigenic Population of Endometrial Adenocarcinoma.

Mamat S, Ikeda J, Tian T, Wang Y, Luo W, Aozasa K, Morii E.

Genes Cancer. 2011 Oct;2(10):979-84. doi: 10.1177/1947601911436009.

7.

Involvement of SIK3 in glucose and lipid homeostasis in mice.

Uebi T, Itoh Y, Hatano O, Kumagai A, Sanosaka M, Sasaki T, Sasagawa S, Doi J, Tatsumi K, Mitamura K, Morii E, Aozasa K, Kawamura T, Okumura M, Nakae J, Takikawa H, Fukusato T, Koura M, Nish M, Hamsten A, Silveira A, Bertorello AM, Kitagawa K, Nagaoka Y, Kawahara H, Tomonaga T, Naka T, Ikegawa S, Tsumaki N, Matsuda J, Takemori H.

PLoS One. 2012;7(5):e37803. doi: 10.1371/journal.pone.0037803. Epub 2012 May 25.

8.

Enormous cystic tumor of peritoneal psammocarcinoma exhibiting complete response to Cisplatin and cyclophosphamide after suboptimal cytoreduction: case report and review of the literature.

Takahashi R, Ueda Y, Shioji M, Adachi S, Ohashi H, Morii E, Aozasa K, Yoshino K, Fujita M, Enomoto T, Kimura T, Tokuhira A.

Gynecol Obstet Invest. 2012;74(2):165-70. Epub 2012 May 11. Review.

PMID:
22584287
9.

Expression level of pre-B-cell leukemia transcription factor 2 (PBX2) as a prognostic marker for gingival squamous cell carcinoma.

Qiu Y, Wang ZL, Jin SQ, Pu YF, Toyosawa S, Aozasa K, Morii E.

J Zhejiang Univ Sci B. 2012 Mar;13(3):168-75. doi: 10.1631/jzus.B1100077.

10.

Reactive oxygen species and aldehyde dehydrogenase activity in Hodgkin lymphoma cells.

Ikeda J, Mamat S, Tian T, Wang Y, Luo W, Rahadiani N, Aozasa K, Morii E.

Lab Invest. 2012 Apr;92(4):606-14. doi: 10.1038/labinvest.2012.4. Epub 2012 Feb 20.

11.

Role of leucine-rich pentatricopeptide repeat motif-containing protein (LRPPRC) for anti-apoptosis and tumourigenesis in cancers.

Tian T, Ikeda J, Wang Y, Mamat S, Luo W, Aozasa K, Morii E.

Eur J Cancer. 2012 Oct;48(15):2462-73. doi: 10.1016/j.ejca.2012.01.018. Epub 2012 Feb 10.

PMID:
22326293
12.

Diffuse large B cell lymphoma with an interfollicular pattern of proliferation shows a favourable prognosis: a study of the Osaka Lymphoma Study Group.

Wada N, Zaki MA, Kohara M, Ogawa H, Sugiyama H, Nomura S, Matsumura I, Hino M, Kanakura Y, Inagaki H, Morii E, Aozasa K.

Histopathology. 2012 May;60(6):924-32. doi: 10.1111/j.1365-2559.2011.04161.x. Epub 2012 Feb 9.

PMID:
22321065
13.

Tumour-associated macrophages in diffuse large B-cell lymphoma: a study of the Osaka Lymphoma Study Group.

Wada N, Zaki MA, Hori Y, Hashimoto K, Tsukaguchi M, Tatsumi Y, Ishikawa J, Tominaga N, Sakoda H, Take H, Tsudo M, Kuwayama M, Morii E, Aozasa K; Osaka Lymphoma Study Group.

Histopathology. 2012 Jan;60(2):313-9. doi: 10.1111/j.1365-2559.2011.04096.x.

PMID:
22211289
14.

Immunohistochemistry of programmed cell death in archival human pathology specimens.

Hasui K, Nagai T, Wang J, Jia X, Aozasa K, Izumo S, Kawano Y, Kanekura T, Eizuru Y, Matsuyama T.

Cells. 2012 May 7;1(2):74-88. doi: 10.3390/cells1020074.

15.

Dysregulated microRNAs affect pathways and targets of biologic relevance in nasal-type natural killer/T-cell lymphoma.

Ng SB, Yan J, Huang G, Selvarajan V, Tay JL, Lin B, Bi C, Tan J, Kwong YL, Shimizu N, Aozasa K, Chng WJ.

Blood. 2011 Nov 3;118(18):4919-29. doi: 10.1182/blood-2011-07-364224. Epub 2011 Sep 14. Erratum in: Blood. 2014 Jan 9;123(2):302.

PMID:
21921041
16.

Prognostic implication of types of tumor-associated macrophages in Hodgkin lymphoma.

Zaki MA, Wada N, Ikeda J, Shibayama H, Hashimoto K, Yamagami T, Tatsumi Y, Tsukaguchi M, Take H, Tsudo M, Morii E, Aozasa K.

Virchows Arch. 2011 Oct;459(4):361-6. doi: 10.1007/s00428-011-1140-8. Epub 2011 Aug 28.

PMID:
21874508
17.

MicroRNA-mediated upregulation of integrin-linked kinase promotes Src-induced tumor progression.

Oneyama C, Morii E, Okuzaki D, Takahashi Y, Ikeda J, Wakabayashi N, Akamatsu H, Tsujimoto M, Nishida T, Aozasa K, Okada M.

Oncogene. 2012 Mar 29;31(13):1623-35. doi: 10.1038/onc.2011.367. Epub 2011 Aug 22.

PMID:
21860426
18.

SIRPĪ±/CD172a regulates eosinophil homeostasis.

Verjan Garcia N, Umemoto E, Saito Y, Yamasaki M, Hata E, Matozaki T, Murakami M, Jung YJ, Woo SY, Seoh JY, Jang MH, Aozasa K, Miyasaka M.

J Immunol. 2011 Sep 1;187(5):2268-77. doi: 10.4049/jimmunol.1101008. Epub 2011 Jul 20.

19.

Indication for sentinel lymph node biopsy for breast cancer when core biopsy shows ductal carcinoma in situ.

Miyake T, Shimazu K, Ohashi H, Taguchi T, Ueda S, Nakayama T, Kim SJ, Aozasa K, Tamaki Y, Noguchi S.

Am J Surg. 2011 Jul;202(1):59-65. doi: 10.1016/j.amjsurg.2010.09.032.

PMID:
21741518
20.

Significance of aldehyde dehydrogenase 1 expression in stromal cells of diffuse large B-cell lymphoma.

Fujita S, Morii E, Rahadiani N, Wada N, Hori Y, Ikeda JI, Aozasa K.

Exp Ther Med. 2011 Jul;2(4):591-594. Epub 2011 May 12.

21.

The prevalence of human papillomavirus in oral premalignant lesions and squamous cell carcinoma in comparison to cervical lesions used as a positive control.

Ishibashi M, Kishino M, Sato S, Morii E, Ogawa Y, Aozasa K, Kogo M, Toyosawa S.

Int J Clin Oncol. 2011 Dec;16(6):646-53. doi: 10.1007/s10147-011-0236-0. Epub 2011 Apr 29.

PMID:
21528380
22.

Pretreatment leukocytosis is an indicator of poor prognosis in patients with cervical cancer.

Mabuchi S, Matsumoto Y, Isohashi F, Yoshioka Y, Ohashi H, Morii E, Hamasaki T, Aozasa K, Mutch DG, Kimura T.

Gynecol Oncol. 2011 Jul;122(1):25-32. doi: 10.1016/j.ygyno.2011.03.037. Epub 2011 Apr 22.

PMID:
21514632
23.

Frequency of intravascular large B-cell lymphoma in Japan: study of the Osaka Lymphoma Study Group.

Chihara T, Wada N, Ikeda J, Fujita S, Hori Y, Ogawa H, Sugiyama H, Nomura S, Matsumura I, Hino M, Kanakura Y, Morii E, Aozasa K.

J Hematol Oncol. 2011 Apr 11;4:14. doi: 10.1186/1756-8722-4-14. No abstract available.

24.

MicroRNA-mediated downregulation of mTOR/FGFR3 controls tumor growth induced by Src-related oncogenic pathways.

Oneyama C, Ikeda J, Okuzaki D, Suzuki K, Kanou T, Shintani Y, Morii E, Okumura M, Aozasa K, Okada M.

Oncogene. 2011 Aug 11;30(32):3489-501. doi: 10.1038/onc.2011.63. Epub 2011 Mar 7.

PMID:
21383697
25.

Presence of B-cell clones in T-cell lymphoma.

Zaki MA, Wada N, Kohara M, Ikeda J, Hori Y, Fujita S, Ogawa H, Sugiyama H, Hino M, Kanakura Y, Morii E, Aozasa K.

Eur J Haematol. 2011 May;86(5):412-9. doi: 10.1111/j.1600-0609.2011.01597.x. Epub 2011 Mar 30.

PMID:
21362051
26.

Epidemiology and pathogenesis of nasal NK/T-cell lymphoma: a mini-review.

Aozasa K, Zaki MA.

ScientificWorldJournal. 2011 Feb 14;11:422-8. doi: 10.1100/tsw.2011.41. Review.

27.

Transcription factors engaged in development of NK cells are commonly expressed in nasal NK/T-cell lymphomas.

Zhang S, Li T, Zhang B, Nong L, Aozasa K.

Hum Pathol. 2011 Sep;42(9):1319-28. doi: 10.1016/j.humpath.2009.11.022. Epub 2011 Feb 16.

PMID:
21329961
28.

Activated oncogenic pathways and therapeutic targets in extranodal nasal-type NK/T cell lymphoma revealed by gene expression profiling.

Ng SB, Selvarajan V, Huang G, Zhou J, Feldman AL, Law M, Kwong YL, Shimizu N, Kagami Y, Aozasa K, Salto-Tellez M, Chng WJ.

J Pathol. 2011 Mar;223(4):496-510. doi: 10.1002/path.2823. Epub 2011 Jan 5.

PMID:
21294123
29.

Pulmonary arterial hypertension associated with chronic active Epstein-Barr virus infection.

Hashimoto T, Sakata Y, Fukushima K, Maeda T, Arita Y, Shioyama W, Nakaoka Y, Hori Y, Morii E, Aozasa K, Kanakura Y, Yamauchi-Takihara K, Komuro I.

Intern Med. 2011;50(2):119-24. Epub 2011 Jan 15.

30.

Expression of aldehyde dehydrogenase 1 (ALDH1) in endometrioid adenocarcinoma and its clinical implications.

Rahadiani N, Ikeda J, Mamat S, Matsuzaki S, Ueda Y, Umehara R, Tian T, Wang Y, Enomoto T, Kimura T, Aozasa K, Morii E.

Cancer Sci. 2011 Apr;102(4):903-8. doi: 10.1111/j.1349-7006.2011.01864.x. Epub 2011 Feb 9.

31.

Epstein-barr virus in diffuse large B-Cell lymphoma in immunocompetent patients in Japan is as low as in Western Countries.

Wada N, Ikeda J, Hori Y, Fujita S, Ogawa H, Soma T, Sugiyama H, Fukuhara S, Kanamaru A, Hino M, Kanakura Y, Morii E, Aozasa K.

J Med Virol. 2011 Feb;83(2):317-21. doi: 10.1002/jmv.21967.

PMID:
21181929
32.

Hepatic follicular dendritic cell sarcoma favorably controlled by transcatheter arterial chemoembolization.

Tsunemine H, Akasaka H, Kusama T, Fujimoto K, Motoyama A, Aozasa K, Kodaka T.

Intern Med. 2010;49(24):2703-7. Epub 2010 Dec 15.

33.

Infiltration of tumour-associated macrophages in prostate biopsy specimens is predictive of disease progression after hormonal therapy for prostate cancer.

Nonomura N, Takayama H, Nakayama M, Nakai Y, Kawashima A, Mukai M, Nagahara A, Aozasa K, Tsujimura A.

BJU Int. 2011 Jun;107(12):1918-22. doi: 10.1111/j.1464-410X.2010.09804.x. Epub 2010 Nov 2.

34.

Tumorigenic potential of mononucleated small cells of Hodgkin lymphoma cell lines.

Ikeda J, Mamat S, Tian T, Wang Y, Rahadiani N, Aozasa K, Morii E.

Am J Pathol. 2010 Dec;177(6):3081-8. doi: 10.2353/ajpath.2010.100089. Epub 2010 Oct 15.

35.

Successful treatment of recurrent small bowel adenocarcinoma by cytoreductive surgery and chemotherapy: a case report and review of the literature.

Yamano T, Morii E, Arai I, Takada T, Aozasa K.

J Med Case Rep. 2010 Jul 17;4:213. doi: 10.1186/1752-1947-4-213.

36.

Porous gelatin particles for uterine artery embolization: an experimental study of intra-arterial distribution, uterine necrosis, and inflammation in a porcine model.

Sone M, Osuga K, Shimazu K, Higashihara H, Nakazawa T, Kato K, Tomabechi M, Ehara S, Nakamura H, Morii E, Aozasa K.

Cardiovasc Intervent Radiol. 2010 Oct;33(5):1001-8. doi: 10.1007/s00270-010-9935-6. Epub 2010 Jul 15.

PMID:
20632007
37.

Diagnosis of primary versus metastatic ovarian adenocarcinoma using p53 gene mutation analysis.

Yamano T, Morii E, Arai I, Takada T, Kubota K, Sato M, Inoue T, Okada Y, Hara T, Aozasa K.

Int J Clin Oncol. 2010 Dec;15(6):621-5. doi: 10.1007/s10147-010-0096-z. Epub 2010 Jun 1.

PMID:
20514505
38.

CD8(+) T-cell lymphoproliferative disorder associated with Epstein-Barr virus in a patient with rheumatoid arthritis during methotrexate therapy.

Hatachi S, Kunitomi A, Aozasa K, Yagita M.

Mod Rheumatol. 2010 Oct;20(5):500-5. doi: 10.1007/s10165-010-0300-z. Epub 2010 May 1.

PMID:
20437072
39.

Diffuse large B-cell lymphoma in the spinal epidural space: A study of the Osaka Lymphoma Study Group.

Wada N, Kohara M, Ikeda J, Hori Y, Fujita S, Okada M, Ogawa H, Sugiyama H, Fukuhara S, Kanamaru A, Hino M, Kanakura Y, Morii E, Aozasa K.

Pathol Res Pract. 2010 Jul 15;206(7):439-44. doi: 10.1016/j.prp.2010.02.003. Epub 2010 Apr 15.

PMID:
20399024
40.

Decreased infiltration of macrophage scavenger receptor-positive cells in initial negative biopsy specimens is correlated with positive repeat biopsies of the prostate.

Nonomura N, Takayama H, Kawashima A, Mukai M, Nagahara A, Nakai Y, Nakayama M, Tsujimura A, Nishimura K, Aozasa K, Okuyama A.

Cancer Sci. 2010 Jun;101(6):1570-3. doi: 10.1111/j.1349-7006.2010.01563.x. Epub 2010 Mar 15.

41.

Prognostic significance of CUB domain containing protein expression in endometrioid adenocarcinoma.

Mamat S, Ikeda J, Enomoto T, Ueda Y, Rahadiani N, Tian T, Wang Y, Qiu Y, Kimura T, Aozasa K, Morii E.

Oncol Rep. 2010 May;23(5):1221-7.

PMID:
20372833
42.

Kaposiform hemangioendothelioma arising in the deltoid muscle without the Kasabach-Merritt phenomenon.

Tamai N, Hashii Y, Osuga K, Chihara T, Morii E, Aozasa K, Yoshikawa H.

Skeletal Radiol. 2010 Oct;39(10):1043-6. doi: 10.1007/s00256-010-0917-1. Epub 2010 Mar 23.

PMID:
20309545
43.

Expression level of Pre B cell leukemia homeobox 2 correlates with poor prognosis of gastric adenocarcinoma and esophageal squamous cell carcinoma.

Qiu Y, Song B, Zhao G, Deng B, Makino T, Tomita Y, Wang J, Luo W, Doki Y, Aozasa K, Morii E.

Int J Oncol. 2010 Mar;36(3):651-63.

PMID:
20126986
44.

Polymorphous lymphoproliferative disorder: a clinicopathological analysis.

Nakamichi N, Wada N, Kohara M, Fukuhara S, Sugiyama H, Ogawa H, Hino M, Kanamaru A, Kanakura Y, Morii E, Aozasa K.

Virchows Arch. 2010 Mar;456(3):269-76. doi: 10.1007/s00428-010-0880-1. Epub 2010 Jan 29.

PMID:
20111873
45.

Tumorigenic role of podoplanin in esophageal squamous-cell carcinoma.

Rahadiani N, Ikeda J, Makino T, Tian T, Qiu Y, Mamat S, Wang Y, Doki Y, Aozasa K, Morii E.

Ann Surg Oncol. 2010 May;17(5):1311-23. doi: 10.1245/s10434-009-0895-5. Epub 2010 Jan 12.

PMID:
20066519
46.

Caspase-1, caspase-8, and calpain are dispensable for IL-33 release by macrophages.

Ohno T, Oboki K, Kajiwara N, Morii E, Aozasa K, Flavell RA, Okumura K, Saito H, Nakae S.

J Immunol. 2009 Dec 15;183(12):7890-7. doi: 10.4049/jimmunol.0802449.

47.

Peripheral T-cell lymphoma developing at ileocolonic anastomosis site after colectomy for adenocarcinoma.

Ikeda J, Yamauchi A, Hoshida Y, Okamura S, Hashimoto K, Aozasa K, Morii E.

Pathol Res Pract. 2010 Jun 15;206(6):376-8. doi: 10.1016/j.prp.2009.08.001.

PMID:
19836149
48.

Diffuse large B-cell lymphoma with a high number of epithelioid histiocytes (lymphoepithelioid B-cell lymphoma): a study of Osaka Lymphoma Study Group.

Wada N, Ikeda J, Kohara M, Ogawa H, Hino M, Fukuhara S, Kanamaru A, Sugiyama H, Kanakura Y, Morii E, Aozasa K.

Virchows Arch. 2009 Sep;455(3):285-93. doi: 10.1007/s00428-009-0827-6.

PMID:
19727807
49.

Tumorigenic role of orphan nuclear receptor NR0B1 in lung adenocarcinoma.

Oda T, Tian T, Inoue M, Ikeda J, Qiu Y, Okumura M, Aozasa K, Morii E.

Am J Pathol. 2009 Sep;175(3):1235-45. doi: 10.2353/ajpath.2009.090010. Epub 2009 Jul 30.

50.

Effect of interleukin-6 receptor blockage on renal injury in apolipoprotein E-deficient mice.

Tomiyama-Hanayama M, Rakugi H, Kohara M, Mima T, Adachi Y, Ohishi M, Katsuya T, Hoshida Y, Aozasa K, Ogihara T, Nishimoto N.

Am J Physiol Renal Physiol. 2009 Sep;297(3):F679-84. doi: 10.1152/ajprenal.90680.2008. Epub 2009 Jul 1.

Supplemental Content

Loading ...
Support Center